ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026
Clinical features and outcomes of spinal involvement in lymphoma: a single-center retrospective study.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeTo investigate the clinical characteristics, neurological manifestations, and survival outcomes of patients with pathologically confirmed spinal lymphoma and to identify factors associated with prognosis.
methodsWe retrospectively reviewed consecutive patients with pathologically confirmed spinal lymphoma treated at the First Affiliated Hospital, Zhejiang University School of Medicine, between Jan 2012 and Dec 2025. Clinical characteristics, treatment patterns, and survival outcomes were analyzed. Overall survival (OS) was estimated using the Kaplan-Meier method, and prognostic factors were evaluated using Cox proportional hazards models.
resultsSixty-three patients were included. The median age was 63 years, and 90.5% presented with primary spinal disease. Pain (82.5%) and neurological impairment (58.7%) were the most common presenting manifestations. Aggressive B-cell lymphoma was the predominant histological subtype (54.0%), and the thoracic spine was the most frequently involved level (61.9%). The estimated 5-year OS was 54% (95% CI, 32%-77%). Neurological impairment, paraplegia, histological subtype, and primary versus secondary spinal involvement were not associated with OS. In multivariable analysis, age >60 years independently predicted inferior survival (HR, 4.04; 95% CI, 1.22-13.39; *P*=0.023).
conclusionsThis study represents one of the largest single-center cohorts of pathologically confirmed spinal lymphoma. Spinal lymphoma most commonly presented with pain, neurological impairment, and thoracic involvement. Although neurological deficits were frequent at diagnosis, they were not independently associated with long-term survival. Older age was the only independent prognostic factor, while the prognostic value of neurological status requires confirmation in larger multicenter studies.
Indexed as
Identifiers
42696037What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.